权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cancer Prevention and Control Research Program

癌症预防与控制研究计划

基本信息

批准号：
10177893
负责人：
PAUL G SPICER
金额：
$ 7.55万
依托单位：
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-05-01 至 2023-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10177893
关键词：
Address Affect American Indians Award Biological Products Cancer Burden Cancer Center Cancer Center Support Grant Cancer Control Cancer Control Research Cancer Control Research Program Caring Catchment Area Direct Costs Disease Progression Emerging Tobacco Products Faculty Funding Goals Grant Intervention Maintenance Malignant Neoplasms Nature Oklahoma Oncology Patients Peer Review Postdoctoral Fellow Publications Publishing Relapse Reporting Research Research Personnel Rural Rural Population Tobacco Tobacco Use Cessation Training Training Programs Training and Education Tribes Trust Underserved Population United States National Institutes of Health Vulnerable Populations addiction base cancer chemoprevention cancer health disparity cancer prevention care coordination care delivery cohort community based participatory research community based research community engaged research graduate student high risk inter-institutional member novel prevent programs tobacco prevention underserved community

项目摘要

CANCER PREVENTION AND CONTROL PROGRAM – ABSTRACT The goal of the Cancer Prevention and Control (CPC) program at the Stephenson Cancer Center (SCC) is to build a robust, transdisciplinary CPC research and training program in order to reduce the burden of cancer in Oklahoma (the SCC catchment area), especially in the state's underserved populations. The program Specific Aims are: 1) to conduct community-engaged research to address the disproportionate burden of cancer affecting American Indian (AI), rural and other underserved populations in the SCC catchment area; 2) to discover the mechanisms underlying tobacco initiation, maintenance, cessation and relapse, and to develop and evaluate novel tobacco treatments targeted to vulnerable and underserved populations; and 3) to discover, develop and apply natural, synthetic and biological agents to prevent, reverse or suppress cancer disease progression in high-risk cohorts in the SCC catchment area and the nation. Highlights of the CPC program include: 1) a highly interactive team of cancer health disparities researchers who have developed collaborative, trust-based relationships with the state's AI and rural populations, leading to NIH-funded community-based research; 2) a highly successful AI Patient Navigation Program that has facilitated access for 1,554 AI patients (representing 54 different tribes) to specialized oncology care at the SCC over the past five years; 3) a growing and highly collaborative team of NIH-funded tobacco investigators who are conducting a wide range of tobacco research, from basic mechanisms of addiction to novel cessation interventions and emerging tobacco products; 4) a nationally recognized cancer chemoprevention team supported by more than $12 million in NCI funding (PREVENT and other) since 2012; and 5) a robust CPC- focused education and training program for under- and graduate students, postdoctoral fellows and junior faculty, with plans for an NIH institutional training grant submission within two years. The CPC program has 27 members, representing 11 departments and a range of transdisciplinary expertise, including cancer health disparities, community-based participatory research, care coordination and delivery, novel interventions for tobacco prevention and cessation, emerging tobacco products, basic mechanisms of addiction and cancer chemoprevention. As of December 31, 2016, CPC program members were awarded $5,575,776 (36 projects) in annual NCI and other peer-reviewed cancer-relevant funding (direct cost). NCI funding ($2,637,717) accounts for nearly half (47.3%) of the peer-reviewed funding, highlighting the program's cancer focus. Total annual CPC program funding is $8,945,333 (direct cost). For the five-year reporting period (2012-2016), CPC program members published 237 peer-reviewed articles, of which 36.3% had intra- programmatic, 5.9% had inter-programmatic, and 64.1% had inter-institutional collaborators. For 2016, intra- programmatic publications were 42.0%, underscoring the highly collaborative nature of CPC program research.

癌症预防和控制程序-摘要